Filing Details

---

CUSIP No. 684023104

Page 2 of 6

1	NAMES OF REPORTING PERSONS
	RANDAL J. KIRK
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☒
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	PF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			4,612,166
		8	SHARED VOTING POWER
			0
		9	SOLE DISPOSITIVE POWER
			4,612,166
		10	SHARED DISPOSITIVE POWER
			0
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	4,612,166
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	9.9%
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IN

1	NAMES OF REPORTING PERSONS
	R.J. KIRK DECLARATION OF TRUST 31-6661283
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☒
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	PF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			3,139,526
		8	SHARED VOTING POWER
			0
		9	SOLE DISPOSITIVE POWER
			3,139,526
		10	SHARED DISPOSITIVE POWER
			0
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	3,139,526
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	6.8%
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO - trust

This Amendment No. 8 (the “Amendment”) amends and supplements the Statement on Schedule 13D, dated June 5, 2012 and filed on June 12, 2012, as amended by Amendment No. 1, dated July 31, 2012 and filed on August 3, 2012, Amendment No. 2, dated September 30, 2013 and filed on October 2, 2013, Amendment No. 3, dated November 20, 2013 and filed on November 22, 2013, Amendment No. 4 dated December 18, 2013 and filed on December 26, 2013, Amendment No. 5 dated December 1, 2015 and filed on December 3, 2015, Amendment No. 6 dated June 30, 2016 and filed July 5, 2016, and Amendment No. 7 dated November 8, 2017 and filed on November 13, 2017 (the “Original Schedule 13D”), relating to the Common Stock, par value $0.001 per share (the “Common Stock”), of Oragenics, Inc., a Florida corporation (the “Company”).  Mr. Randal J. Kirk (“Mr. Kirk”) and the R.J. Kirk Declaration of Trust, a revocable trust established by Mr. Kirk (“RJ DOT” and, together with Mr. Kirk, the “Reporting Persons”), are filing this Amendment to disclose the purchase by entities under the common control of Mr. Kirk of 3,064,000 shares of Common Stock, in open market transactions between January 31, 2020 and March 2, 2020.

Except as set forth below, there are no changes to the information set forth in the Original Schedule 13D.

 

Item 3 of the Original Schedule 13D is hereby amended and supplemented as follows:

 

Randal J. Kirk and entities under his common control utilized working capital to purchase 3,064,000 shares of Common Stock, in open market transactions between January 31, 2020 and March 2, 2020, for an aggregate purchase price of approximately $1,894,941.

 

 

Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows:

 

The information set forth in Items 3 and 6 is incorporated herein by reference.

The shares disclosed herein were acquired by the Reporting Persons for investment purposes.

 

Items 5(a) and (b) of the Original Schedule 13D are hereby amended and restated to read in their entirety as follows:

 

(a) and (b)          See items 11 and 13 of the cover pages to this Statement for the aggregate number of shares and percentage of issued and outstanding shares of Common Stock of the Company owned by the Reporting Persons. The percentage ownership is calculated based on 46,124,803 shares of Common Stock issued and outstanding as of November 8, 2019 as disclosed in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2019 and filed on November 14, 2019, as adjusted for a 1-for-10 reverse stock split that became effective on January 19, 2018.

 

CUSIP No. 684023104

Page 5 of 6

Reporting Person		Amount of Common Stock Beneficially Owned (1)		Percent of Class		Sole Power to Vote or Direct the Vote(1)		Shared Power to Vote or Direct the Vote			Sole Power to Dispose or to Direct the Disposition(1)		Shared Power to Dispose or to Direct the Disposition
Randal J. Kirk		4,612,166(2)		9.9%		4,612,166(2)			--		4,612,166(2)			--
R.J. Kirk Declaration of Trust		3,139,526		6.8%		3,139,526			--		3,139,526

(1)

The indicated share amounts reflect a 1-for-10 reverse stock split effected by the Company on January 19, 2018.

 

(2)

Includes shares of Common Stock held by various entities that are managed by Third Security, LLC, a Virginia limited liability company that is managed by Mr. Kirk (“Third Security”), none of which beneficially owns more than 5.0% individually.

 

Mr. Kirk could be deemed to have indirect beneficial ownership of the shares of Common Stock directly beneficially owned by the RJ DOT.

 

(c)          On January 1, 2020, TS Biotechnology Holdings, LLC (“TS Biotechnology”) and Precigen, Inc., formerly known as Intrexon Corporation, entered into a Stock and Asset Purchase Agreement, pursuant to which TS Biotechnology purchased from Precigen, 1,448,110 shares of Common Stock and 113.941 shares of the Company’s Series C, Non-Voting, Non-Convertible Preferred Stock (collectively, the “Purchase Agreement Shares”).  At closing, TS Biotechnology elected to have the Purchase Agreement Shares issued directly to its members, all of which are either entities managed by Third Security or for which Mr. Kirk serves as Trustee.

Except as disclosed herein, none of the Reporting Persons have engaged in any transactions in the Company’s Common Stock in the past 60 days.

 

Item 6 of the Original Schedule 13D is hereby amended and supplemented as follows:

 

The Reporting Persons’ response to Item 3 is incorporated herein by reference.

 

 

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Date:  March 2, 2020
	/s/ Randal J. Kirk
	Randal J. Kirk
	R.J. KIRK DECLARATION OF TRUST
	By:	/s/ Randal J. Kirk
		Randal J. Kirk
		Trustee